Harm reduction responses to COVID-19 for women who use drugs: country examples.
This paper was initially prepared as a briefing document to support a presentation for the 64th session of the Commission on Narcotic Drugs multi-stakeholder consultation on the impact of the COVID-19 pandemic on health services for people who use drugs who are living with or are vulnerable to HIV 7- 8 April session on “Considering diversity and gender: Women who use drugs”. It has also been shared with the Women and Harm Reduction International Network (WHRIN) members as a living advocacy tool to expand gender sensitive responses to COVID strictures for women who use drugs. Many thanks to the WHRIN members and others who contributed.